{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [], "OtherID": [], "CitationSubset": ["IM"], "InvestigatorList": [], "SpaceFlightMission": [], "GeneralNote": [], "OtherAbstract": [], "PMID": "25825910", "DateCompleted": {"Year": "2016", "Month": "03", "Day": "21"}, "DateRevised": {"Year": "2021", "Month": "11", "Day": "03"}, "Article": {"ArticleDate": [{"Year": "2015", "Month": "03", "Day": "31"}], "ELocationID": ["e0122374", "10.1371/journal.pone.0122374"], "Language": ["eng"], "Journal": {"ISSN": "1932-6203", "JournalIssue": {"Volume": "10", "Issue": "3", "PubDate": {"Year": "2015"}}, "Title": "PloS one", "ISOAbbreviation": "PLoS One"}, "ArticleTitle": "Specific medicinal plant polysaccharides effectively enhance the potency of a DC-based vaccine against mouse mammary tumor metastasis.", "Pagination": {"StartPage": "e0122374", "MedlinePgn": "e0122374"}, "Abstract": {"AbstractText": ["Dendritic cell (DC) vaccines are a newly emerging immunotherapeutic approach for the treatment and prevention of cancer, but major challenges still remain particularly with respect to clinical efficacy. Engineering and optimization of adjuvant formulations for DC-based vaccines is one strategy through which more efficacious treatments may be obtained. In this study, we developed a new ex vivo approach for DC vaccine preparation. We evaluated two highly purified mixed polysaccharide fractions from the root of Astragalus membranaceus and Codonopsis pilosulae, named Am and Cp, for their use in enhancing the efficiency of a DC-based cancer vaccine against metastasis of 4T1 mammary carcinoma in mice. Mixed lymphocyte reaction showed all Am-, Cp- and [Am+Cp]-treated DCs enhanced mouse CD4+ and CD8+ T-cell proliferation. [Am+Cp]-treated DCs exhibited the strongest anti-4T1 metastasis activity in test mice. Treatments with Am, Cp and [Am+Cp] also resulted in augmented expression of CD40, CD80 and CD86 markers in test DCs. Bioinformatics analysis of the cytokine array data from treated DCs identified that [Am+Cp] is efficacious in activation of specific immune functions via mediating the expression of cytokines/chemokines involved in the recruitment and differentiation of defined immune cells. Biochemical analysis revealed that Am and Cp are composed mainly of polysaccharides containing a high level (70-95%) glucose residues, but few or no (< 1%) mannose residues. In summary, our findings suggest that the specific plant polysaccharides Am and Cp extracted from traditional Chinese medicines can be effectively used instead of bacterial LPS as a potent adjuvant in the formulation of a DC-based vaccine for cancer immunotherapies."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Food and Nutrition, Providence University, Taichung, Taiwan, R. O. C; Institute of Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan, R. O. C."}], "LastName": "Chang", "ForeName": "Wei Ting", "Initials": "WT"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Development Center for Biotechnology, New Taipei City, Taiwan, R. O. C."}], "LastName": "Lai", "ForeName": "Tzung Hsien", "Initials": "TH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Development Center for Biotechnology, New Taipei City, Taiwan, R. O. C."}], "LastName": "Chyan", "ForeName": "Yau Jan", "Initials": "YJ"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan, R. O. C."}], "LastName": "Yin", "ForeName": "Shu Yi", "Initials": "SY"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan, R. O. C."}], "LastName": "Chen", "ForeName": "Yung Hsiang", "Initials": "YH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan, R. O. C."}], "LastName": "Wei", "ForeName": "Wen Chi", "Initials": "WC"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Institute of Agricultural Biotechnology Research Center, Academia Sinica, Taipei, Taiwan, R. O. C."}], "LastName": "Yang", "ForeName": "Ning-Sun", "Initials": "NS"}], "PublicationTypeList": ["Journal Article", "Research Support, Non-U.S. Gov't"]}, "MedlineJournalInfo": {"Country": "United States", "MedlineTA": "PLoS One", "NlmUniqueID": "101285081", "ISSNLinking": "1932-6203"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Cancer Vaccines"}, {"RegistryNumber": "0", "NameOfSubstance": "Polysaccharides"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["immunology", "therapeutic use"], "DescriptorName": "Cancer Vaccines"}, {"QualifierName": [], "DescriptorName": "Cell Line, Tumor"}, {"QualifierName": [], "DescriptorName": "Cell Proliferation"}, {"QualifierName": ["immunology"], "DescriptorName": "Dendritic Cells"}, {"QualifierName": [], "DescriptorName": "Female"}, {"QualifierName": ["pathology", "surgery"], "DescriptorName": "Mammary Neoplasms, Experimental"}, {"QualifierName": [], "DescriptorName": "Mice"}, {"QualifierName": [], "DescriptorName": "Mice, Inbred BALB C"}, {"QualifierName": ["prevention & control"], "DescriptorName": "Neoplasm Metastasis"}, {"QualifierName": ["chemistry"], "DescriptorName": "Plants, Medicinal"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Polysaccharides"}, {"QualifierName": ["cytology", "immunology"], "DescriptorName": "T-Lymphocytes"}], "CoiStatement": "<b>Competing Interests: </b>The authors have declared that no competing interests exist."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Cardoso F, Harbeck N, Fallowfield L, Kyriakides S, Senkus E, ESMO Guidelines Working Group. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2012;23 Suppl 7: vii11\u201319.", "ArticleIdList": ["22997442"]}, {"Citation": "Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61: 69\u201390. 10.3322/caac.20107", "ArticleIdList": ["10.3322/caac.20107", "21296855"]}, {"Citation": "Vulink A, Radford KJ, Melief C, Hart DNJ. Dendritic Cells in Cancer Immunotherapy. 2008; 99: 363\u2013407.", "ArticleIdList": ["18037410"]}, {"Citation": "Dubensky TW Jr, Reed SG. Adjuvants for cancer vaccines. Semin Immunol. 2010;22: 155\u2013161. 10.1016/j.smim.2010.04.007", "ArticleIdList": ["10.1016/j.smim.2010.04.007", "20488726"]}, {"Citation": "Park JW, Melisko ME, Esserman LJ, Jones LA, Wollan JB, Sims R. Treatment with autologous antigen-presenting cells activated with the HER-2 based antigen Lapuleucel-T: results of a phase I study in immunologic and clinical activity in HER-2 overexpressing breast cancer. J Clin Oncol. 2007;25: 3680\u20133687.", "ArticleIdList": ["17704416"]}, {"Citation": "O'Neill DW, Adams S, Bhardwaj N. Manipulating dendritic cell biology for the active immunotherapy of cancer. Blood. 2004;104: 2235\u20132246.", "ArticleIdList": ["15231572"]}, {"Citation": "Cintolo JA, Datta J, Mathew SJ, Czerniecki BJ. Dendritic cell-based vaccines: barriers and opportunities. Future Oncol. 2010;8: 1273\u20131299. 10.1097/JTO.0b013e3181dea6be", "ArticleIdList": ["10.1097/JTO.0b013e3181dea6be", "PMC4260651", "23130928"]}, {"Citation": "Pavelko KD, Heckman KL, Hansen MJ, Pease LR. An effective vaccine strategy protective against antigenically distinct tumor variants. Cancer Res. 2008;68: 2471\u20132478. 10.1158/0008-5472.CAN-07-5937", "ArticleIdList": ["10.1158/0008-5472.CAN-07-5937", "18381456"]}, {"Citation": "Chen HM, Wang PH, Chen SS, Wen CC, Chen YH, Yang WC, et al. Shikonin induces immunogenic cell death in tumor cells and enhances dendritic cell-based cancer vaccine. Cancer Immunol Immunother. 2012;16: 1989\u20132002.", "ArticleIdList": ["22527248"]}, {"Citation": "Figdor CG, de Vries IJ, Lesterhuis WJ, Melief CJ. Dendritic cell immunotherapy: mapping the way. Nat Med. 2004;10: 475\u2013480.", "ArticleIdList": ["15122249"]}, {"Citation": "Hatfield P, Merrick AE, West E, O'Donnell D, Selby P, Vile R, et al. Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother. 2008;31: 620\u2013632. 10.1097/CJI.0b013e31818213df", "ArticleIdList": ["10.1097/CJI.0b013e31818213df", "PMC3901408", "18600182"]}, {"Citation": "Steinman RM, Pope M. Exploiting dendritic cells to improve vaccine efficacy. J Clin Invest. 2002;109: 1519\u20131526.", "ArticleIdList": ["PMC151021", "12070296"]}, {"Citation": "Hubo M, Trinschek B, Kryczanowsky F, Tuettenberg A, Steinbrink K, Jonuleit H. Costimulatory molecules on immunogenic versus tolerogenic human dendritic cells. Front Immunol. 2013;4: 82 10.3389/fimmu.2013.00082", "ArticleIdList": ["10.3389/fimmu.2013.00082", "PMC3615188", "23565116"]}, {"Citation": "Carter D, Reed SG. Role of adjuvants in modeling the immune response. Curr Opin HIV AIDS. 2010;5: 409\u2013413. 10.1097/COH.0b013e32833d2cdb", "ArticleIdList": ["10.1097/COH.0b013e32833d2cdb", "PMC3894736", "20978382"]}, {"Citation": "Breckpot K, Escors D. Dendritic cells for active anti-cancer immunotherapy: targeting activation pathways through genetic modification. Endocr Metab Immune Disord Drug Targets. 2009;9: 328\u2013343.", "ArticleIdList": ["PMC2797000", "19857199"]}, {"Citation": "Chang WT, Chen HM, Yin SY, Chen YH, Wen CC, Wei WC, et al. Specific Dioscorea Phytoextracts Enhance Potency of TCL-Loaded DC-Based Cancer Vaccines. Evid Based Complement Alternat Med. 2013;2013: 1\u201313.", "ArticleIdList": ["PMC3723319", "23935688"]}, {"Citation": "Jin M, Zhao K, Huang Q, Shang P. Structural features and biological activities of the polysaccharides from Astragalus membranaceus. Int J Biol Macromol. 2013;64C: 257\u2013266.", "ArticleIdList": ["24325861"]}, {"Citation": "Shao BM, Xu W, Dai H, Tu P, Li Z, Gao XM. A study on the immune receptors for polysaccharides from the roots of Astragalus membranaceus, a Chinese medicinal herb. Biochem Biophys Res Commun. 2004;320: 1103\u20131111.", "ArticleIdList": ["15249203"]}, {"Citation": "Cho WC, Leung KN. In vitro and in vivo anti-tumor effects of Astragalus membranaceus. Cancer Lett. 2007;252: 43\u201354.", "ArticleIdList": ["17223259"]}, {"Citation": "Zheng YS, Wu ZS, Ni HB, Ke L, Tong ZH, Li WQ, et al. Codonopsis pilosula Polysaccharide Attenuates Cecal Ligation and Puncture Sepsis via Circuiting Regulatory T Cells in Mice. Shock. 2014;41: 250\u2013255. 10.1097/SHK.0000000000000091", "ArticleIdList": ["10.1097/SHK.0000000000000091", "24296433"]}, {"Citation": "Xu C, Liu Y, Yuan G, Guan M. The contribution of side chains to antitumor activity of a polysaccharide from Codonopsis pilosula. Int J Biol Macromol. 2012;50: 891\u2013894. 10.1016/j.ijbiomac.2012.01.013", "ArticleIdList": ["10.1016/j.ijbiomac.2012.01.013", "22285989"]}, {"Citation": "Dong J, Su SY, Wang MY, Zhan Z. Shenqi fuzheng, an injection concocted from Chinese medicinal herbs, combined with platinum-based chemotherapy for advanced non-small cell lung cancer: a systematic review. J Exp Clin Cancer Res. 2010;29: 137 10.1186/1756-9966-29-137", "ArticleIdList": ["10.1186/1756-9966-29-137", "PMC2972256", "20969765"]}, {"Citation": "Wang J, Tong X, Li P, Cao H, Su W. Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice. J Ethnopharmacol. 2012;139: 788\u2013795. 10.1016/j.jep.2011.12.019", "ArticleIdList": ["10.1016/j.jep.2011.12.019", "22212503"]}, {"Citation": "Hsu CH, Peng KL, Kang ML, Chen YR, Yang YC, Tsai CH, et al. TET1 suppresses cancer invasion by activating the tissue inhibitors of metalloproteinases. Cell Rep. 2012;2: 568\u2013579. 10.1016/j.celrep.2012.08.030", "ArticleIdList": ["10.1016/j.celrep.2012.08.030", "22999938"]}, {"Citation": "Yin SY, Wang CY, Yang NS. Interleukin-4 enhances trafficking and functional activities of GM-CSF-stimulated mouse myeloid-derived dendritic cells at late differentiation stage. Exp Cell Res. 2011;317: 2210\u20132221. 10.1016/j.yexcr.2011.06.013", "ArticleIdList": ["10.1016/j.yexcr.2011.06.013", "21741972"]}, {"Citation": "Jung MY, Son MH, Kim SH, Cho D, Kim TS. IL-32gamma induces the maturation of dendritic cells with Th1- and Th17-polarizing ability through enhanced IL-12 and IL-6 production. J Immunol. 2011;186: 6848\u20136859. 10.4049/jimmunol.1003996", "ArticleIdList": ["10.4049/jimmunol.1003996", "21551364"]}, {"Citation": "Cataldi TRI, Campa C, Margiotta G, Bufo SA. Role of Barium Ions in the Anion-Exchange Chromatographic Separation of Carbohydrates with Pulsed Amperometric Detection. Anal Chem. 1998;70: 3940\u20133945."}, {"Citation": "Keene JA, Forman J. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J Exp Med. 1982;155: 768\u2013782.", "ArticleIdList": ["PMC2186611", "6801178"]}, {"Citation": "Marzo AL, Kinnear BF, Lake RA, Frelinger JJ, Collins EJ, Robinson BW, et al. Tumor-specific CD4+ T cells have a major \"post-licensing\" role in CTL mediated anti-tumor immunity. J Immunol.2000;165: 6047\u20136055.", "ArticleIdList": ["11086036"]}, {"Citation": "Ossendorp F, Mengede E, Camps M, Filius R, Melief CJ. Specific T helper cell requirement for optimal induction of cytotoxic T lymphocytes against major histocompatibility complex class II negative tumors. J Exp Med. 1998;187: 693\u2013702.", "ArticleIdList": ["PMC2212165", "9480979"]}, {"Citation": "Dell'Agnola C, Biragyn A. Clinical utilization of chemokines to combat cancer: the double-edged sword. Expert Rev Vaccines. 2007;6: 267\u2013283.", "ArticleIdList": ["PMC2262932", "17408375"]}, {"Citation": "Dranoff G. Cytokines in cancer pathogenesis and cancer therapy. Nat Rev Cancer. 2004;4: 11\u201322.", "ArticleIdList": ["14708024"]}, {"Citation": "Griffith JW, Sokol CL, Luster AD. Chemokines and chemokine receptors: positioning cells for host defense and immunity. Annu Rev Immunol. 2014;32: 659\u2013702. 10.1146/annurev-immunol-032713-120145", "ArticleIdList": ["10.1146/annurev-immunol-032713-120145", "24655300"]}, {"Citation": "Bleharski JR, Kiessler V, Buonsanti C, Sieling PA, Stenger S, Colonna M, et al. A role for triggering receptor expressed on myeloid cells-1 in host defense during the early-induced and adaptive phases of the immune response. J Immunol. 2003;170: 3812\u20133818.", "ArticleIdList": ["12646648"]}, {"Citation": "Joosten SA, van Meijgaarden KE, Savage ND, de Boer T, Triebel F, van der Wal A, et al. Identification of a human CD8+ regulatory T cell subset that mediates suppression through the chemokine CC chemokine ligand 4. Proc Natl Acad Sci U S A. 2007;104: 8029\u20138034.", "ArticleIdList": ["PMC1876566", "17483450"]}, {"Citation": "Simson L, Ellyard JI, Dent LA, Matthaei KI, Rothenberg ME, Foster PS, et al. Regulation of carcinogenesis by IL-5 and CCL11: a potential role for eosinophils in tumor immune surveillance. J Immunol. 2007;178: 4222\u20134229.", "ArticleIdList": ["17371978"]}, {"Citation": "Hong M, Puaux AL, Huang C, Loumagne L, Tow C, Mackay C, et al. Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control. Cancer Res. 2011;71: 6997\u20137009. 10.1158/0008-5472.CAN-11-1466", "ArticleIdList": ["10.1158/0008-5472.CAN-11-1466", "21948969"]}, {"Citation": "Roberts NJ, Zhou S, Diaz LA Jr, Holdhoff M. Systemic use of tumor necrosis factor alpha as an anticancer agent. Oncotarget. 2001;2: 739\u2013751.", "ArticleIdList": ["PMC3248159", "22036896"]}, {"Citation": "Liu SH, Cheng YC. Old formula, new Rx: the journey of PHY906 as cancer adjuvant therapy. J Ethnopharmacol. 2012;140: 614\u2013623. 10.1016/j.jep.2012.01.047", "ArticleIdList": ["10.1016/j.jep.2012.01.047", "22326673"]}, {"Citation": "Rockwell S, Grove TA, Liu Y, Cheng YC, Higgins SA, Booth CJ. Preclinical studies of the Chinese Herbal Medicine formulation PHY906 (KD018) as a potential adjunct to radiation therapy. Int J Radiat Biol. 2013;89: 16\u201325. 10.3109/09553002.2012.717733", "ArticleIdList": ["10.3109/09553002.2012.717733", "PMC3660854", "22856538"]}, {"Citation": "Yoo DG, Kim MC, Park MK, Park KM, Quan FS, Song JM, et al. Protective effect of ginseng polysaccharides on influenza viral infection. PLoS One. 2012;7: e33678 10.1371/journal.pone.0033678", "ArticleIdList": ["10.1371/journal.pone.0033678", "PMC3307756", "22442708"]}, {"Citation": "El Enshasy HA, Hatti-Kaul R. Mushroom immunomodulators: unique molecules with unlimited applications. Trends Biotechnol. 2013;31: 668\u2013677. 10.1016/j.tibtech.2013.09.003", "ArticleIdList": ["10.1016/j.tibtech.2013.09.003", "24125745"]}, {"Citation": "Ramberg JE, Nelson ED, Sinnott RA. Immunomodulatory dietary polysaccharides: a systematic review of the literature. Nutr J. 2010;9: 54 10.1186/1475-2891-9-54", "ArticleIdList": ["10.1186/1475-2891-9-54", "PMC2998446", "21087484"]}, {"Citation": "Nergard CS, Matsumoto T, Inngjerdingen M, Inngjerdingen K, Hokputsa S, Harding SE, et al. Structural and immunological studies of a pectin and a pectic arabinogalactan from Vernonia kotschyana Sch. Bip. ex Walp. (Asteraceae). Carbohydr Res. 2005;340: 115\u2013130.", "ArticleIdList": ["15620674"]}, {"Citation": "Robinson MJ, Sancho D, Slack EC, Leibund Gut-Landmann S, Reis e Sousa C. Myeloid C-type lectins in innate immunity. Nat Immunol. 2006;7: 1258\u20131265.", "ArticleIdList": ["17110942"]}, {"Citation": "Hsu DK, Chernyavsky AI, Chen HY, Yu L, Grando SA, Liu FT. Endogenous galectin-3 is localized in membrane lipid rafts and regulates migration of dendritic cells. J Invest Dermatol. 2009;129: 573\u2013583. 10.1038/jid.2008.276", "ArticleIdList": ["10.1038/jid.2008.276", "PMC2645233", "18843294"]}, {"Citation": "Pyz E, Marshall AS, Gordon S, Brown GD. C-type lectin-like receptors on myeloid cells. Ann Med. 2006;38: 242\u2013251.", "ArticleIdList": ["16754255"]}, {"Citation": "Demicheli R, Valagussa P, Bonadonna G. Does surgery modify growth kinetics of breast cancer micrometastases? Br J Cancer. 2001;85: 490\u2013492.", "ArticleIdList": ["PMC2364103", "11506484"]}, {"Citation": "Ben-Eliyahu S. The promotion of tumor metastasis by surgery and stress: immunological basis and implications for psychoneuroimmunology. Brain Behav Immun. 2003;17 Suppl 1: S27\u201336.", "ArticleIdList": ["12615183"]}, {"Citation": "van der Bij GJ, Oosterling SJ, Beelen RH, Meijer S, Coffey JC, van Egmond M. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg. 2009;249: 727\u2013734. 10.1097/SLA.0b013e3181a3ddbd", "ArticleIdList": ["10.1097/SLA.0b013e3181a3ddbd", "19387333"]}, {"Citation": "Klebanoff CA, Gattinoni L, Restifo NP. CD8+ T-cell memory in tumor immunology and immunotherapy. Immunol Rev. 2006;211: 214\u2013224.", "ArticleIdList": ["PMC1501075", "16824130"]}, {"Citation": "Lenschow DJ, Walunas TL, Bluestone JA. CD28/B7 system of T cell costimulation. Annu Rev Immunol. 1996;14: 233\u2013258.", "ArticleIdList": ["8717514"]}, {"Citation": "Pufnock JS, Cigal M, Rolczynski LS, Andersen-Nissen E, Wolfl M, McElrath MJ, et al. Priming CD8+ T cells with dendritic cells matured using TLR4 and TLR7/8 ligands together enhances generation of CD8+ T cells retaining CD28. Blood. 2011;117: 6542\u20136551. 10.1182/blood-2010-11-317966", "ArticleIdList": ["10.1182/blood-2010-11-317966", "PMC3123022", "21493800"]}, {"Citation": "Dolfi DV, Duttagupta PA, Boesteanu AC, Mueller YM, Oliai CH, Borowski AB, et al. Dendritic cells and CD28 costimulation are required to sustain virus-specific CD8+ T cell responses during the effector phase in vivo. J Immunol. 2011;186: 4599\u20134608. 10.4049/jimmunol.1001972", "ArticleIdList": ["10.4049/jimmunol.1001972", "21389258"]}, {"Citation": "van Duikeren S, Fransen MF, Redeker A, Wieles B, Platenburg G, Krebber WJ, et al. Vaccine-induced effector-memory CD8+ T cell responses predict therapeutic efficacy against tumors. J Immunol. 2012;189: 3397\u20133403.", "ArticleIdList": ["22914049"]}, {"Citation": "Cho HI, Celis E. Optimized peptide vaccines eliciting extensive CD8 T-cell responses with therapeutic antitumor effects. Cancer Res. 2009;69: 9012\u20139019. 10.1158/0008-5472.CAN-09-2019", "ArticleIdList": ["10.1158/0008-5472.CAN-09-2019", "PMC2789207", "19903852"]}, {"Citation": "Galon J, Costes A, Sanchez-Cabo F, Kirilovsky A, Mlecnik B, Lagorce-Pag\u00e8s C, et al. Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science. 2006;313: 1960\u20131964.", "ArticleIdList": ["17008531"]}, {"Citation": "Hu J, Zhu S, Xia X, Zhang L, Kleinerman ES, Li S. CD8+T cell-specific induction of NKG2D receptor by doxorubicin plus interleukin-12 and its contribution to CD8+T cell accumulation in tumors. Mol Cancer. 2014;13: 34 10.1186/1476-4598-13-34", "ArticleIdList": ["10.1186/1476-4598-13-34", "PMC3938086", "24565056"]}, {"Citation": "Ridge JP, Di Rosa F, Matzinger P. A conditioned dendritic cell can be a temporal bridge between a CD4+ T-helper and a T-killer cell. Nature. 1998;393: 474\u2013478.", "ArticleIdList": ["9624003"]}, {"Citation": "Schoenberger SP, Toes RE, van der Voort EI, Offringa R, Melief CJ. T-cell help for cytotoxic T lymphocytes is mediated by CD40-CD40L interactions. Nature. 1998;393: 480\u2013483.", "ArticleIdList": ["9624005"]}, {"Citation": "Diehl L, den Boer AT, Schoenberger SP, van der Voort EI, Schumacher TN, Melief CJ, et al. CD40 activation in vivo overcomes peptide-induced peripheral cytotoxic T-lymphocyte tolerance and augments anti-tumor vaccine efficacy. Nat Med. 1999;5: 774\u2013779.", "ArticleIdList": ["10395322"]}, {"Citation": "Toes RE, Schoenberger SP, van der Voort EI, Offringa R, Melief CJ. CD40-CD40Ligand interactions and their role in cytotoxic T lymphocyte priming and anti-tumor immunity. Semin Immunol. 1998;10: 443\u2013448.", "ArticleIdList": ["9826577"]}, {"Citation": "Chan GC, Chan WK, Sze DM. The effects of beta-glucan on human immune and cancer cells. J Hematol Oncol. 2009;2: 25 10.1186/1756-8722-2-25", "ArticleIdList": ["10.1186/1756-8722-2-25", "PMC2704234", "19515245"]}, {"Citation": "Jonuleit H, Kuhn U, Muller G, Steinbrink K, Paragnik L, Schmitt E, et al. Pro-inflammatory cytokines and prostaglandins induce maturation of potent immunostimulatory dendritic cells under fetal calf serum-free conditions. Eur J Immunol. 1997;27: 3135\u20133142.", "ArticleIdList": ["9464798"]}, {"Citation": "Ridolfi R, Petrini M, Fiammenghi L, Stefanelli M, Ridolfi L, Ballardini M, et al. Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients. J Transl Med. 2006;4: 36", "ArticleIdList": ["PMC1562447", "16914047"]}, {"Citation": "Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Br\u00f6cker EB, et al. Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG. Ann Oncol. 2006;17: 563\u2013570.", "ArticleIdList": ["16418308"]}, {"Citation": "Qu C, Edwards EW, Tacke F, Angeli V, Llodra J, Sanchez-Schmitz G, et al. Role of CCR8 and other chemokine pathways in the migration of monocyte-derived dendritic cells to lymph nodes. J Exp Med. 2004;200: 1231\u20131241.", "ArticleIdList": ["PMC2211916", "15534368"]}, {"Citation": "Adema GJ, Hartgers F, Verstraten R, de Vries E, Marland G, Menon S, et al. A dendritic-cell-derived C-C chemokine that preferentially attracts naive T cells. Nature. 1997;387: 713\u2013717.", "ArticleIdList": ["9192897"]}, {"Citation": "Ramos CD, Canetti C, Souto JT, Silva JS, Hogaboam CM, Ferreira SH, et al. MIP-1alpha[CCL3] acting on the CCR1 receptor mediates neutrophil migration in immune inflammation via sequential release of TNF-alpha and LTB4. J Leukoc Biol. 2005;78: 167\u2013177.", "ArticleIdList": ["15831559"]}, {"Citation": "Castellino F, Huang AY, Altan-Bonnet G, Stoll S, Scheinecker C, Germain RN. Chemokines enhance immunity by guiding naive CD8+ T cells to sites of CD4+ T cell-dendritic cell interaction. Nature. 2006;440: 890\u2013895.", "ArticleIdList": ["16612374"]}, {"Citation": "Yoneyama H, Narumi S, Zhang Y, Murai M, Baggiolini M, Lanzavecchia A, et al. Pivotal role of dendritic cell-derived CXCL10 in the retention of T helper cell 1 lymphocytes in secondary lymph nodes. J Exp Med. 2002;195: 1257\u20131266.", "ArticleIdList": ["PMC2193754", "12021306"]}, {"Citation": "Osterholm MT. Preparing for the next pandemic. N Engl J Med. 2005;352: 1839\u20131842.", "ArticleIdList": ["15872196"]}], "ReferenceList": []}], "History": [{"Year": "2014", "Month": "8", "Day": "1"}, {"Year": "2015", "Month": "2", "Day": "13"}, {"Year": "2015", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "4", "Day": "1", "Hour": "6", "Minute": "0"}, {"Year": "2016", "Month": "3", "Day": "22", "Hour": "6", "Minute": "0"}, {"Year": "2015", "Month": "3", "Day": "31"}], "PublicationStatus": "epublish", "ArticleIdList": ["25825910", "PMC4380423", "10.1371/journal.pone.0122374", "PONE-D-14-32356"]}}], "PubmedBookArticle": []}